Lawrence H. Schwartz
Artificial Intelligence · 2003–2019
A researcher in the Science corpus: 12 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Artificial Intelligence — 61 citations into it
Whom Lawrence H. Schwartz trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Diederik P. Kingma (in Artificial Intelligence)
- Max Welling (in Artificial Intelligence)
Papers from Lawrence H. Schwartz's perspective
Ordered by how strongly the researchers Lawrence H. Schwartz trusts endorse each paper. Same corpus, a different order for every researcher.
- ImageNet classification with deep convolutional neural networks
- Auto-Encoding Variational Bayes (International Conference on Learning Representations)
- Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper
- Support-Vector Networks
- Random Forests
- Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning
- The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository (Journal of digital imaging)
- New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). (European Journal of Cancer)
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach (Nature Communications)
- Radiomics: Extracting more information from medical images using advanced feature analysis (European Journal of Cancer)
Their papers
- The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS) (2015) — 6,325 citations
- Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. (2006) — 1,204 citations
- New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). (2009) — 26,513 citations
- Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer. (2005) — 913 citations
- Artificial intelligence in Cancer Imaging: Clinical Challenges and Applications (2019) — 1,608 citations
- Artificial intelligence in radiology (2018) — 3,232 citations
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. (2016) — 1,381 citations
- Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. (2007) — 1,363 citations
- Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer (2007) — 638 citations
- Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. (2005) — 1,142 citations
- Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. (2004) — 761 citations
- Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. (2003) — 659 citations